BORDERLINE OVARIAN SEROUS TUMOR

Clinical trials for BORDERLINE OVARIAN SEROUS TUMOR explained in plain language.

Never miss a new study

Get alerted when new BORDERLINE OVARIAN SEROUS TUMOR trials appear

Sign up with your email to follow new studies for BORDERLINE OVARIAN SEROUS TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for controlling a tough ovarian cancer

Disease control Completed

This study tested whether a drug called trametinib was better than standard treatments at controlling recurrent low-grade ovarian or peritoneal cancer. It involved 260 patients whose cancer had returned or worsened after prior chemotherapy. Participants were randomly assigned to …

Matched conditions: BORDERLINE OVARIAN SEROUS TUMOR

Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

BORDERLINE OVARIAN SEROUS TUMOR

Get alerted when new BORDERLINE OVARIAN SEROUS TUMOR trials appear

New hope for controlling a tough ovarian cancer